Innovent Biologics, Inc. (IVBIY)
OTCMKTS
· Delayed Price · Currency is USD
22.29
-0.67 (-2.90%)
At close: Mar 31, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $11.67 billion as of April 24, 2025. Its market cap has increased by 46.38% in one year.
Market Cap
11.67B
Enterprise Value
10.98B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$22.29
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 11.67B, an increase of 393.77%. That is a compound annual growth rate of 27.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.74B |
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Elite Pharmaceuticals | 436.82M |
| Northwest Biotherapeutics | 402.62M |
| Glass House Brands | 384.26M |
| CytoDyn | 264.36M |